|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA04000106
|
Ectocarpin D
|
(5E,8E,11E)-12-{(1'R,2'S,3'S,5'S)-2',3'-dihydroxy-5'-[(1''R)-1''-hydroxypropyl]cyclopentyl}-5,8,11-dodecatrienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04000105
|
Ectocarpin C
|
(5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-hydroxypropyl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA04000104
|
Ectocarpin B
|
(5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-propen-1''-yl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid
|
FA 20:6;O
|
C20H28O3
|
316.203846
|
|
LMFA04000107
|
C20-OPDA
|
(5Z,8Z)-10-(4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)deca-5,8-dienoic acid
|
FA 20:6;O
|
C20H28O3
|
316.203846
|
|
LMFA04010523
|
4-F3t-NeuroP
|
(4S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-undeca-2,5,8-dien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04000108
|
17S-HDHA-d5
|
17S-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O3
|
349.266529
|
|
LMFA04050008
|
Maresin 1-d5
|
7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O4
|
365.261444
|
|
LMFA04040007
|
Neuroprotectin D1-d5
|
10R,17S-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O4
|
365.261444
|
|
LMFA04030017
|
Resolvin D1-d5
|
7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O5
|
381.256359
|
|
LMFA04030018
|
Resolvin D3-d5
|
4S,11R,17S-trihydroxy-5Z,7E,9E,13Z,15E,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O5
|
381.256359
|
|
LMFA04030019
|
7,17-DiHDPA
|
7S,17S-dihydroxy-8E,10Z,13Z,15E,19Z-Docosapentaenoic acid
|
FA 22:5;O2
|
C22H34O4
|
362.245711
|
|
LMFA04040008
|
17(R)-Neuroprotectin D1
|
10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA04050009
|
Maresin 2-d5
|
13R,14S-dihydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H27D5O4
|
365.261444
|
|
LMFA04000109
|
17-oxo-DPA
|
17-oxo-7Z,10Z,13Z,15E,19Z-docosapentaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000110
|
(+/-)19(20)-DiHDTE
|
19,20-dihydroxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:4;O2
|
C22H36O4
|
364.261361
|
|
LMFA04000111
|
(+/-)19(20)-EpDTE
|
19,20-epoxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000112
|
(+/-)7(8)-EpDTE
|
7,8-epoxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000113
|
(+/-)7(8)-DiHDTE
|
7,8-dihydroxydocosa-7Z,10Z,13Z,16Z-tetraenoic acid
|
FA 22:4;O2
|
C22H36O4
|
364.261361
|
|
LMFA04000115
|
17S-HpDoTE
|
17S-hydroperoxy-7Z,10Z,13Z,15E-docosatetraenoic acid
|
FA 22:4;O2
|
C22H36O4
|
364.261361
|
|
LMFA04000116
|
(+/-)13,14-DiHDoTrE
|
13,14-dihydroxy-7Z,10Z,16Z-docosatrienoic acid
|
FA 22:3;O2
|
C22H38O4
|
366.277011
|
|
LMFA04000117
|
(+/-)13,14-EDT
|
13,14-epoxy-7Z,10Z,16Z-docosatrienoic acid
|
FA 22:4;O
|
C22H36O3
|
348.266446
|
|
LMFA04000114
|
17S-HDoTE
|
17S-hydroxy-7Z,10Z,13Z,15E-docosatetraenoic acid
|
FA 22:4;O
|
C22H36O3
|
348.266446
|
|
LMFA04000118
|
3-HDPE
|
3-Hydroxy-7Z,10Z,13Z,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000119
|
17-oxo-DPE (DPA n6)
|
17-oxo-4Z,7Z,10Z,13Z,15E-docosapentaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA04000120
|
17S-HDPE (DPA n6)
|
17S-hydroxy-4Z,7Z,10Z,13Z,15E-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000121
|
17S-HDPE (DPA n3)
|
17S-hydroxy-7Z,10Z,13Z,15E,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04010524
|
(+/-)4-F4t-NeuroP
|
(E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010525
|
4-epi-F3t-NeuroP
|
(4R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-undeca-2,5,8-dien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04020529
|
17(RS)-10-epi-SC-D15-11-dihomo-IsoF
|
(R,Z)-10-hydroxy-10-((2S,4S,5S)-4-hydroxy-5-((E)-3-hydroxyoct-1-en-1-yl)tetrahydrofuran-2-yl)dec-7-enoic acid
|
FA 22:3;O4
|
C22H38O6
|
398.266841
|
|
LMFA04020530
|
7(RS)-ST-delta8-11-dihomo-IsoF
|
(10S,E)-7,10-dihydroxy-10-((2S,4R,5S)-4-hydroxy-5-((Z)-oct-2-en-1-yl)tetrahydrofuran-2-yl)dec-8-enoic acid
|
FA 22:4;O4
|
C22H38O6
|
398.266841
|
|
LMFA04030020
|
Resolvin D2-d5
|
7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic-21,21,22,22,22-d5 acid
|
|
C22H28D5O5
|
381.256359
|
|
LMFA04010528
|
14-F3t-NeuroP-DPAomega-3
|
1a,1b-dihomo-8S,10R,14S-trihydroxy-12E,16Z,19Z-prostatrienoic acid-cyclo[7S,11R]
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04010527
|
20-F3t-NeuroP-DPAn-3
|
12-((1S,2R,3R,5S)-3,5-dihydroxy-3S-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04010526
|
20-epi-20-F3t-NeuroP-DPAn-3
|
12-((1S,2R,3R,5S)-3,5-dihydroxy-3R-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid
|
FA 22:4;O3
|
C22H36O5
|
380.256276
|
|
LMFA04000126
|
dihomo-TXB2
|
9S,11,15S-trihydroxy-2,3-dihomo-thromboxa-5Z,13E-dien-1-oic acid
|
FA 22:3;O4
|
C22H38O6
|
398.266841
|
|
LMFA04000122
|
|
14-Hydroxy-7Z,10Z,12E,16Z-docosatetraenoic acid
|
FA 22:4;O
|
C22H36O3
|
348.266446
|
|
LMFA04000123
|
|
14-hydroxy-7Z,10Z,12E,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000124
|
|
11-hydroxy-7Z,9E,13Z,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000125
|
|
14-hydroxy-4Z,7Z,10Z,12E,16Z-docosapentaenoic acid
|
FA 22:5;O
|
C22H34O3
|
346.250796
|
|
LMFA04000127
|
10,13,14-bis alpha-dihomo TrXA5
|
10,13,14S-trihydroxy-4Z,7Z,11E,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04000128
|
7,10,11S-bis alpha-dihomo TrXA5
|
7,10,11S-trihydroxy-4Z,7Z,11E,16Z,19Z-docosapentaenoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|